Objective
To develop an understanding of the molecular pathology of Huntington's disease (HD) and neurodegenerative diseases caused by CAG expansion thereby laying the ground work for the development of therapeutic strategies.
This will involve the identification of the normal function of the huntingtin (htt) protein, the changes brought about by a CAG expansion, the generation of cellular and animal model systems of HD and the initiation of a parallel analysis of Machado Joseph disease (SCA3).
A number of inherited, late onset, neurodegenerative disorders have been described which show anticipation when the respective gene is inherited through the male line. The neurodegeneration is selective, differs between the diseases and its biochemical basis is unknown. Isolation of the genes for five of these diseases: HD, SBMA, SCA1, DRPLA and MJD (SCA3) has shown the underlying mutation to be a CAG expansion. In all cases, the identification of the mutation has led to accurate diagnostic tests, and an understanding of the molecular basis of some of the genetic features, but it has done little to uncover the chain of events leading to the observed neuropathology. In all cases the repeat lies within the coding region and codes for a stretch of polyglutamine residues (polygln). It is particularly fascinating that these proteins can tolerate such a wide variation in the polygln size within the normal range, yet the further addition of a few residues causes the disease, and, that this apparently universal mutation, when present in different disease genes causes such strikingly selective cell death. An understanding of this process is central to the eventual design of methods to prevent or delay the onset or interrupt the progression of these diseases.
We plan to carry out a comprehensive analysis of the molecular basis of HD and MJD. A unique set of complementary resources, in the form of antibodies and clones has already been generated by the partners. The normal function of huntingtin (htt), its cellular interactions and the mechanism by which the polyglutamine expansion changes this function must be established. In situ hybridisation, immunohistochemistry, immunoelectron microscopy and western analysis will be used to determine the cellular localisation of htt and SCA3 proteins and quantify their expression in normal and affected brains. An interspecies comparative sequence analysis of htt and its homologues will be used to identify functional domains. Htt will be expressed in vitro to allow the identification of interacting proteins. Cellular and animal models of HD will be developed using cDNA and genomic constructs carrying expansions, both to produce transgenic mice and for the introduction into neuronal cell lines. Such models are essential to study the disease mechanism and to allow the future testing of therapeutic agents that may block the progression of these devastating diseases for which there are no effective therapies.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences neurobiology
- natural sciences biological sciences biochemistry biomolecules proteins
- natural sciences physical sciences optics microscopy
- natural sciences biological sciences genetics mutation
- medical and health sciences basic medicine pathology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
SE1 9RT London
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.